Table 1.
Patients’ characteristics
| Parameters | Group I (NS) |
Group II (IV dexmedetomidine) | Group III (IP Dexmedetomidine) |
P | P cumulative | |||
|---|---|---|---|---|---|---|---|---|
| Mean±SD | Range | Mean±SD | Range | Mean±SD | Range | |||
| Age (years) | 42.84±11.49 | 25-60 | 34.56±10.42 | 19-55 | 33.56±9.18 | 18-53 | 0.02* 0.94† 0.017‡ |
0.004 |
| Weight (kg) | 55.60±9.66 | 42-80 | 53.56±9.42 | 40-72 | 53.28±10.30 | 40-70 | 0.74* 0.99† 0.68‡ |
0.660 |
| Duration of surgery (mean±SD) (in min) | 118.20±26.09 min | 109.20±18.64 min | 105.56±24.71 min | 0.34* 0.85† 0.14‡ |
0.16 | |||
| ASA I (%) | 23 (92%) | 24 (96%) | 23 (92%) | 0.855 | ||||
| ASAII (%) | 2 (8%) | 1 (4%) | 2 (8%) | 0.761 | ||||
NS – Normal saline group, IV – Intravenous, IP – Intraperitoneal dexmedetomidine, SD – Standard deviation. *Level of significance between Groups NS and IV. †Level of significance between Groups IV and IP. ‡Level of significance between group NS and IP. P<0.02 is considered statistically significant